|

Biomarkers for Prediction of Tumor Response to Radiotherapy

RECRUITINGSponsored by Chuangzhen Chen
Actively Recruiting
SponsorChuangzhen Chen
Started2018-10-29
Est. completion2025-11-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03744819

Summary

This study aims to explore potential biomarkers for prediction of therapeutic outcomes in patients with solid tumors after radiotherapy

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Pathological proven diagnosis of solid tumors
* Tumor accessible for biopsy during the course of radiotherapy or tumor samples could be obtained via surgery
* Patient must provide study-specific informed consent prior to study entry

Exclusion Criteria:

* History of autoimmune diseases
* History of immunotherapy
* Prior radiation therapy that would result in overlap of planned radiation therapy fields
* Will receive immunotherapy during the course of radiotherapy
* Contraindications for biopsy, such as high bleeding risk

Conditions2

CancerSolid Tumors

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.